India  

PM Modi reaches Hyderabad to visit Bharat Biotech plant

IndiaTimes Saturday, 28 November 2020
PM Modi will be proceeding to Bharat Biotech's facility located at Genome valley, a life sciences cluster about 20 km from the AF base, officials said. Covid-19 vaccine, Covaxin, being developed byBharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology is now undergoing phase-3 trials. The vaccine is being developed and will be manufactured at Bharat Biotech's BSL-3 (Bio-Safety Level 3) facility in Genome Valley in Hyderabad.
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: PM Modi visits Bharat Biotech facility to review COVID vaccine development

PM Modi visits Bharat Biotech facility to review COVID vaccine development 01:15

Prime Minister Narendra Modi on November 28 visited Bharat Biotech facility in Hyderabad to review the COVID-19 vaccine development. Earlier in the day, PM also visited the Zydus Biotech Park in Ahmedabad to review the development of COVID-19 vaccine candidate ZyCOV-D. PM Modi will also visit Serum...

You Might Like


💡 newsR Knowledge: Other News Mentions

Hyderabad Hyderabad Capital of Telangana, India

Hyderabad-based non-profit organisation provides free education to tribal children [Video]

Hyderabad-based non-profit organisation provides free education to tribal children

Once a child labour, Santosh, who is currently running his own NGO in Hyderabad, provides free primary education to the tribal children. People Helping Children was set up in 2019 and aims towards providing solution to the problems faced by the underprivileged children. Education and nutritious food are the two top priorities of the NGO. With branches in 6 states, NGO runs with the support of around 50 members and over 1000 volunteers. Founder of People Helping Children, Santosh said, "I lost my childhood, I worked as a child labourer, so I don't want anyone to lose their childhood, this is the main reason, why I started this NGO." The goal of this NGO is that every child gets primary education in the country.

Credit: ANI    Duration: 03:08Published
Vaccines approved only after testing: G Kishan Reddy confident of efficacy [Video]

Vaccines approved only after testing: G Kishan Reddy confident of efficacy

Minister of State for Home Affairs G Kishan Reddy inaugurated vaccination drive at Gandhi Hospital in Hyderabad on January 16. On the rumours around the efficacy of the vaccine, G Kishan Reddy said that medicines tested in other countries are considered good but when our scientists toil and develop made in India medicines, people view it like that. He further assured that vaccines have been approved only after testing."I request people to not say such things. Medicines tested in other countries are considered good but when our scientists toil and develop made in India medicines, people view it like that. I request not to discuss things like this. Vaccines have been approved only after testing. I say this confidently that the vaccines will benefit everyone," said MoS Home Affairs G Kishan Reddy.

Credit: ANI    Duration: 01:11Published
COVID-19 vaccination drive begins in India [Video]

COVID-19 vaccination drive begins in India

The mega COVID-19 vaccination drive began in India on January 16. Prime Minister Narendra Modi launched the drive and around 100 healthcare workers will get vaccinated at each session site on the inaugural day. Manish Kumar, a sanitation worker, became the first person to receive COVID-19 vaccine jab at AIIMS. In the first phase of COVID-19 vaccination drive, healthcare workers will receive the vaccine. The beneficiaries reached to their respective health centres. Two COVID vaccines have been approved in India- Pune-based SII's 'Covishield' and Hyderabad-based Bharat Biotech's 'Covaxin'.

Credit: ANI    Duration: 01:41Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Centre issues Letter of Comfort to Bharat Biotech for 45 lakh doses of Covaxin

Bharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of its COVID-19 vaccine, Covaxin, sources said. ​​Out of the..
IndiaTimes

COVID-19: Who shouldn't take Covaxin? Bharat Biotech releases factsheet as concerns grow

Bharat Biotech issued the factsheet just two days after the launch of vaccination drive in the country.
DNA
Covid vaccine: How many Indians got jab on Day 1? Govt reveals [Video]

Covid vaccine: How many Indians got jab on Day 1? Govt reveals

At least 1,65,714 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi. About 16,755 total vaccinators involved across India during the COVID vaccination drive. There was no post adverse event reported after the vaccination was administered to the people. "Total vaccinators involved across India were 16,755. Total beneficiaries vaccinated across India--1,65,714. COVID19 vaccination drive was successful on Day 1. No case of post-vaccination hospitalisation reported so far," said Manohar Agnani, Additional Secretary of Union Health Ministry. "The Serum Institute of India (SII) produced COVISHIELD was supplied to all States and Union Territories (UT). Bharat Biotech's COVAXIN was supplied to 12 States. Total 3,351 sessions were held across the country with both the vaccines, said Health Ministry on COVID19 vaccine roll-out," he added. Watch the full video for more details.

Credit: HT Digital Content    Duration: 06:46Published
First feeling, side-effects, doubts: Vaccinated doctors share experience [Video]

First feeling, side-effects, doubts: Vaccinated doctors share experience

On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made Covishield jabs respectively. Both didn't experience any side-effects and said that doubts regarding the inoculants are unfounded. Dr Suranjit Chatterjee of Apollo hospital, who is set to receive a shot soon, also weighed in on the controversy regarding Covaxin and its third phase trials. Watch the full video for more.

Credit: HT Digital Content    Duration: 08:15Published

Narendra Modi Narendra Modi 14th and current Prime Minister of India

‘If India does not give China a clear message...’: Rahul Gandhi warns govt [Video]

‘If India does not give China a clear message...’: Rahul Gandhi warns govt

Rahul Gandhi warned the Modi government over China’s aggression in Ladakh and said that the government needs have a decisive strategy to counter the threat. ‘Unlike India, China has a very clear strategic vision. They want to shape the world. India does not have a strategic vision. China has tested India once before in Doklam and now in Ladakh. If China is not given a clear message, then China will not remain quiet, they will take advantage of it,’ Rahul Gandhi said. He said that he was raising the red-flag for the government. Rahul Gandhi also added that the government cannot sort this issue through event management and accused the Modi government of failing to protect India. Watch the full video for all the details.

Credit: HT Digital Content    Duration: 03:51Published
‘Who gave Balakot information to Arnab Goswami?’: Rahul Gandhi questions govt [Video]

‘Who gave Balakot information to Arnab Goswami?’: Rahul Gandhi questions govt

RahuL Gandhi launched an attack on the Modi government over the alleged leaked charts of journalist Arnab Goswami, which purportedlky reveal that he had priori information about the Balakot airstrike. Rahul Gandhi said that leaking such kind of top secret information is a criminal act. He added that those who leaked the information and the recipient should both be booked. Rahul further asked that only the PM, Defence Minister or the NSA would be privy to such information and questioned who had leaked it to the journalist. Watch the full video for all the details.

Credit: HT Digital Content    Duration: 03:00Published
Surat hit-run case: PM announces ex-gratia of Rs 2 lakh each for kin of deceased [Video]

Surat hit-run case: PM announces ex-gratia of Rs 2 lakh each for kin of deceased

Death toll mounted to 15 in Surat's hit and run case on January 19. Prime Minister Narendra Modi expressed his deepest condolences on the truck accident tragedy. He also announced to give ex-gratia of Rs 2 lakh each from PMNRF (Prime Minister's National Relief Fund) to next of the kin of the deceased. And Rs 50,000 each would be given to those injured. Gujarat CM Vijay Rupani also announced an ex-gratia of Rs 2 Lakhs each to the next of the kin of those who lost their lives in the accident in Surat. The labourers were sleeping on the pavement of the Palod village, when the truck driver lost his control and drove it over the sleeping workers. All the deceased hailed from Rajasthan. 13 people died on spot.

Credit: ANI    Duration: 01:38Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

‘3,81,305 beneficiaries received Covid vaccine, 580 adverse events’: Health Ministry [Video]

‘3,81,305 beneficiaries received Covid vaccine, 580 adverse events’: Health Ministry

Union Health Ministry informed that a total of 3,81,305 beneficiaries have so far been vaccinated for Covid-19 and 580 adverse events following immunisation were reported in the country till 5 PM on January 18. Addressing a press briefing, Manohar Agnani, Additional Secretary in the ministry of health, said 1,48,266 beneficiaries were vaccinated across 25 states and union territories till 5 pm on Monday. “A total of 3,81,305 beneficiaries have so far been vaccinated (till 5 pm on Monday) till today through 7,704 sessions, as per the provisional reports,” the ministry said. Agnani said a cumulative 580 adverse events following immunisation (AEFIs) and seven hospitalisations have so far been reported in the country since the nationwide Covid inoculation drive began on January 16. Watch the full video for more.

Credit: HT Digital Content    Duration: 03:17Published
Brazil begins COVID vaccinations amid delay of ingredient imports [Video]

Brazil begins COVID vaccinations amid delay of ingredient imports

Lagging immunisation drive further hampered by wait on active ingredients from abroad to finish doses for distribution.

Credit: Al Jazeera STUDIO    Duration: 02:46Published

One in eight had coronavirus in England by December last year, survey estimates

At least one in eight people in England had had COVID-19 by December last year, new survey data estimates.
Sky News

Cambodian PM Hun Sen seeks India's assistance for Covid-19 vaccine

The Cambodian Prime Minister Hun Sen on Monday requested the Indian government to provide the Covid-19 vaccine during his meeting with the new Indian ambassador..
IndiaTimes

Indian Council of Medical Research Indian Council of Medical Research

India records 10,064 new COVID cases in last 24 hours [Video]

India records 10,064 new COVID cases in last 24 hours

As per the data released by Ministry of Health and Family Welfare (MoHFW), India on January 19 reported single-day spike of 10,064 new coronavirus cases in the last 24 hours. 137 deaths in the same period pushed the COVID-19 toll in the country to 1,52,556. India's confirmed cases of coronavirus stand at 1,05,81,837 which include 2,00,528 active infections. More than 1,02,28,753 people have recovered from the virus with 17,411 new discharges in last 24 hours. According to Indian Council of Medical Research (ICMR), a total of 7,09,791 samples were tested on January 18. Cumulative samples tested for COVID-19 till January 18 are 18,78,02,827.

Credit: ANI    Duration: 01:12Published
India records 13,788 new COVID cases in last 24 hours [Video]

India records 13,788 new COVID cases in last 24 hours

As per the data released by Ministry of Health and Family Welfare (MoHFW), India on January 18 reported single-day spike of 13,788 new coronavirus cases in the last 24 hours. 145 deaths in the same period pushed the COVID-19 toll in the country to 1,52,419. India's confirmed cases of coronavirus stand at 1,05,71,773 which include 2,08,012 active infections. More than 1,02,11,342 people have recovered from the virus with 14,457 new discharges in last 24 hours. According to Indian Council of Medical Research (ICMR), a total of 5,48,168 samples were tested on January 17. Cumulative samples tested for COVID-19 till January 17 are 18,70,93,036.

Credit: ANI    Duration: 01:26Published
COVID-19: Total cases cross 1.05 crore-mark in India [Video]

COVID-19: Total cases cross 1.05 crore-mark in India

On January 16, total COVID-19 tally of India reached to 1,05,42,841. The country reported 15,158 new COVID-19 cases in last 24 hours and active cases stands at 2,11,033. With new 16,977 discharges, total number reached to 1,01,79715. 175 deaths were reported in last 24 hours, taking cumulative toll to 1,52,093. According to ICMR, total number of samples tested up to 11th January is 18,57,65,491 and of these, 8,03,090 samples were tested yesterday.

Credit: ANI    Duration: 01:52Published

National Institute of Virology Indian virology research institute

Vaccine drive accelerates, doses reach far corners of India

While SII moved about 56 lakh doses of Covishield to 13 cities, Hyderabad-based Bharat Biotech said it had successfully transported the indigenous Covaxin,..
IndiaTimes
Bharat Biotech vaccine could've advantage over others on new strain, hopes ICMR DG [Video]

Bharat Biotech vaccine could've advantage over others on new strain, hopes ICMR DG

Director General of ICMR, Dr. Balram Bhargava, said that indigenously developed Bharat Biotech vaccine might have some advantages over other vaccines on the new strain of COVID that was found in UK. He said, "NIV scientists have successfully isolated the new virus strain and this will be tested against different vaccines. We hope potentially Bharat Biotech vaccine will have some advantages over other vaccines on this new strain because it is a whole virus." "New virus variant which is now more than 60% infective and creating havoc in the UK is worrisome. There are 29 patients in India with the same variant for which we should be cautious. We have been able to isolate the new virus very soon," added Dr. Balram Bhargava.

Credit: ANI    Duration: 01:49Published
PGIMER sends 80 random samples to Pune to check for new virus strain [Video]

PGIMER sends 80 random samples to Pune to check for new virus strain

Post Graduate Institute of Medical Education and Research Director Jagat Ram said that the institute has sent 80 random samples of patients who tested positive for COVID-19 since September to National Institute of Virology, Pune to ascertain if there is mutation in the virus. The PGIMER director informed that 20 samples each from the last four months have been sent.

Credit: ANI    Duration: 01:38Published

Related videos from verified sources

Free Covid vaccine for Delhi residents? CM Kejriwal comments ahead of launch [Video]

Free Covid vaccine for Delhi residents? CM Kejriwal comments ahead of launch

Delhi Chief Minister Arvind Kejriwal commented on the impending launch of mass immunisation against Covid-19. India will begin vaccinations on January 16. Vaccines are being shipped to various centres..

Credit: HT Digital Content     Duration: 02:39Published
First batch of Bharat Biotech's 'Covaxin' arrives at Delhi airport [Video]

First batch of Bharat Biotech's 'Covaxin' arrives at Delhi airport

The first consignment of 'Covaxin', the COVID-19 vaccine by Hyderabad-based Bharat Biotech arrived at Delhi's Indira Gandhi International Airport on Jan 13. Three boxes of 'Covaxin' are also being..

Credit: ANI     Duration: 01:18Published
Covid vaccine: Congress minister's appeal to Modi govt after Jan 16 launch move [Video]

Covid vaccine: Congress minister's appeal to Modi govt after Jan 16 launch move

On the day that the Union government announced the launch date of Covid-19 vaccination in the country, Chhattisgarh health minister TS Singh Deo made an appeal. The Congress leader said that the Centre..

Credit: HT Digital Content     Duration: 03:58Published

Related news from verified sources

Sputnik V vaccine shows 92% efficacy, says Russia

Russia's National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund on Wednesday announced that the Sputnik V vaccine, the...
Mid-Day

Mumbai: BMC identifies 1 lakh frontline workers who will get COVID-19 vaccine first

The *Brihanmumbai Municipal Corporation* (BMC), the country's richest civic body, has identified 1 lakh frontline workers who will be given the COVID-19 vaccine....
Mid-Day

COVID-19 vaccine for priority groups without location bias: Health Ministry

Refuting the rumours surrounding the rollout of Covid-19 vaccine administration, the Union Health Ministry clarified on Tuesday that the vaccine would be...
Mid-Day